<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activation of the Evi-1 gene was first described to be associated with the transformation of murine <z:mpath ids='MPATH_342'>myeloid leukaemias</z:mpath> and has previously been detected in cases of human <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:mp ids='MP_0005481'>CML</z:mp>) in <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crises</z:e> and in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we determined the frequency and the level of Evi-1 expression in juvenile <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>) and in <z:mpath ids='MPATH_458'>normal</z:mpath> haemopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>Using RT-PCR and Southern blot hybridization <z:chebi fb="2" ids="33699">mRNA</z:chebi> of Evi-1 could be detected in bone marrow (BM) and peripheral blood (PB) mononuclear cells (MNC) of <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> 12/20 patients examined expressed elevated levels of Evi-1 compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="4" pm="."><plain>In these samples over-expression of the gene was correlated with a higher percentage of blasts (P = 0.02) </plain></SENT>
<SENT sid="5" pm="."><plain>Expression levels in BFU-E and CFU-GM derived colonies from BM of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> patients were lower than those in the corresponding MNC samples </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of CD34+ and CD34- cells demonstrated that Evi-1 is primarily expressed in the CD34+ cell population of both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="7" pm="."><plain>These findings suggest that Evi-1 expression is linked to the early stages of haemopoiesis </plain></SENT>
<SENT sid="8" pm="."><plain>Studies on the regulation of Evi-1 expression in CD34+ cells will elucidate its function in progenitor cells and clarify its possible role in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> </plain></SENT>
</text></document>